Skip to Content
Global News Select

UnitedHealth Posts Stronger 2Q Revenue, Reduced Profit Amid Higher Medical Costs

By Matt Grossman


UnitedHealth Group Inc. Thursday logged higher revenue in the latest quarter, but its earnings fell year over year as the company paid out more as people sought healthcare they had deferred during the Covid-19 pandemic last year.

The Minnetonka, Minn.-based health insurer logged earnings attributable to shareholders of $4.46 a share, compared with $6.91 a share in the same quarter a year earlier. Total net earnings attributable to shareholders were $4.27 billion, down from $6.64 billion 12 months ago.

Excluding one-time items, the company posted adjusted earnings of $4.70 a share. Analysts surveyed by FactSet were forecasting adjusted earnings of $4.43 a share

Revenue climbed to $71.32 billion, from $62.14 billion in 2020's second quarter. Analysts were estimating revenue of $69.5 billion.

Revenue in the UnitedHealthcare insurance segment climbed to $55.5 billion, from $49.1 billion in the year-ago period. The medical-care ratio, a measure of the proportion of premiums paid out to cover health expenses, was 83%, compared with 70% a year earlier.

UnitedHealthcare's operating earnings declined to $3.1 billion, from $7 billion a year earlier, as people sought medical care they had deferred during the Covid-19 pandemic, the company said.

Revenue from the Optum health-services business was higher at $38.3 billion, compared with $32.7 billion a year earlier.


Write to Matt Grossman at


(END) Dow Jones Newswires

July 15, 2021 06:27 ET (10:27 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.